- Home
- TLSA vs NEOV Comparison
TLSA vs NEOV Comparison
Compare TLSA & NEOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSA | NEOV |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.1M | 129.2M |
| IPO Year | 2017 | 2022 |
Fundamental Metrics
Financial Performance| Metric | TLSA | NEOV |
|---|---|---|
| Price | $1.18 | $2.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $8.02 | ★ $9.75 |
| AVG Volume (30 Days) | 582.2K | ★ 1.3M |
| Earning Date | 05-01-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,332,953.00 |
| Revenue This Year | N/A | $623.96 |
| Revenue Next Year | N/A | $344.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 58.22 |
| 52 Week Low | $0.76 | $1.36 |
| 52 Week High | $2.20 | $7.13 |
Technical Indicators
Market Signals| Indicator | TLSA | NEOV |
|---|---|---|
| Relative Strength Index (RSI) | 60.42 | 41.49 |
| Support Level | $1.14 | $2.52 |
| Resistance Level | $1.20 | $3.23 |
| Average True Range (ATR) | 0.09 | 0.22 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 76.81 | 34.77 |
Price Performance
Historical ComparisonAbout TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.